University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Grace E. Kim, MD

Grace E. Kim, MD

Clinical Professor, Vice Chair of Clinical Services, Department of Pathology, UCSF
Distinguished Professor of Anatomic Pathology, UCSF

Cancer Center Program Memberships

Experimental Therapeutics

Education

Pacific Union College, Angwin, CA, BS, 1989, Chemistry
Loma Linda University, Loma Linda, CA, Post Sophomore Fellow, 1992-1993, Anatomic Pathology
Loma Linda Univ. School of Medicine, Loma Linda, CA, MD, 1995, Medicine
Stanford University Medical Center, Stanford, CA, Intern, 1995-1996, Anatomic Pathology
Stanford University, Stanford, CA, Resident, 1996-1997, Anatomic Pathology
Stanford University, Stanford, CA, Fellow, 1997-1998, Surgical Pathology
Children’s Medical Center of Dallas, Dallas, TX, Fellow, 1998-1999, Pediatric Pathology


Professional Experience

  • 1999-2000
    Staff Pathologist (Fee Basis), Veterans Affairs Medical Center, San Francisco
  • 2/2000-6/2000
    Clinical Instructor, Department of Pathology, University of California, San Francisco
  • 7/2000-6/2002
    Staff Pathologist, Department of Veterans Affairs Medical Center, San Francisco
  • 2000-2006
    Assistant Professor, Department of Pathology, University of California, San Francisco
  • 2005-2011
    Associate Director of Surgical Pathology and Medical Director of Gross Room, Department of Pathology, University of California, San Francisco
  • 2006-2010
    Associate Professor, Department of Pathology, University of California, San Francisco
  • 2010-present
    Clinical Professor, Department of Pathology, University of California, San Francisco
  • 2011-2015
    Co-Director of Surgical Pathology and Medical Director of Gross Room, Department of Pathology, University of California, San Francisco
  • 2015-2016
    Director of Anatomic Pathology, Medical Director of Gross Room, CLIA Laboratory Director, Department of Pathology, University of California, San Francisco
  • 2016-Present
    Distinguished Professor, Vice Chair of Clinical Services, and CLIA Laboratory Director, Department of Pathology, University of California, San Francisco

Honors & Awards

  • 1989
    Richard A. Jackson Memorial Scholarship
  • 1993-94
    Post Sophomore Pathology Fellowship Scholarship
  • 1999
    A. James McAdams Short Term Study Stipend Award
  • 2002
    Nominated by UCSF Medical School Class of 2004 for "Excellence in Small Group/Lab Instruction"
  • 2008-2009
    University of California San Francisco School of Medicine Teaching Award from Department of Pathology, Anatomic Pathology Residents and Fellows

Selected Publications

  1. Wen KW, Umetsu SE, Goldblum JR, Gill RM, Kim GE, Joseph NM, Rabinovitch PS, Kakar S, Lauwers GY, Choi WT. DNA Flow Cytometric and Interobserver Study of "Crypt Cell Atypia" in Inflammatory Bowel Disease. Histopathology. 2019 May 20.
    View on PubMed
  2. Wen KW, Kim GE, Rabinovitch PS, Wang D, Mattis AN, Choi WT. Diagnosis, risk stratification, and management of ampullary dysplasia by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol. 2019 Apr 11.
    View on PubMed
  3. Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization? Am J Surg Pathol. 2019 Mar; 43(3):334-340.
    View on PubMed
  4. Bove KE, Thrasher AD, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim GE, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC. Inflammation, Active Fibroplasia, and End-stage Fibrosis in 172 Biliary Atresia Remnants Correlate Poorly With Age at Kasai Portoenterostomy, Visceral Heterotaxy, and Outcome. Am J Surg Pathol. 2018 Dec; 42(12):1625-1635.
    View on PubMed
  5. Cui D, Peng Y, Zhang C, Li Z, Su Y, Qi Y, Xing M, Li J, Kim GE, Su KN, Xu J, Wang M, Ding W, Piecychna M, Leng L, Hirasawa M, Jiang K, Young L, Xu Y, Qi D, Bucala R. Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy. J Clin Invest. 2018 Nov 01; 128(11):4997-5007.
    View on PubMed
  6. Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, Hawkins DS, Sweet-Cordero EA. Genome-Informed Targeted Therapy for Osteosarcoma. Cancer Discov. 2019 01; 9(1):46-63.
    View on PubMed
  7. Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Mol Cancer Ther. 2018 Dec; 17(12):2702-2709.
    View on PubMed
  8. Shamir ER, Devine WP, Pekmezci M, Umetsu SE, Krings G, Federman S, Cho SJ, Saunders TA, Jen KY, Bergsland E, Jones K, Kim GE, Kakar S, Chiu CY, Joseph NM. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Mod Pathol. 2019 Feb; 32(2):290-305.
    View on PubMed
  9. Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making? Surgery. 2018 Dec; 164(6):1178-1184.
    View on PubMed
  10. Tsuda M, Fukuda A, Roy N, Hiramatsu Y, Leonhardt L, Kakiuchi N, Hoyer K, Ogawa S, Goto N, Ikuta K, Kimura Y, Matsumoto Y, Takada Y, Yoshioka T, Maruno T, Yamaga Y, Kim GE, Akiyama H, Ogawa S, Wright CV, Saur D, Takaori K, Uemoto S, Hebrok M, Chiba T, Seno H. The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis. J Clin Invest. 2018 Aug 01; 128(8):3475-3489.
    View on PubMed
  11. Muraki T, Kim GE, Reid MD, Mittal P, Bedolla G, Memis B, Pehlivanoglu B, Freedman A, Erbarut Seven I, Choi H, Kooby D, Maithel SK, Sarmiento JM, Krasinskas A, Adsay V. Paraduodenal Pancreatitis: Imaging and Pathologic Correlation of 47 Cases Elucidates Distinct Subtypes and the Factors Involved in its Etiopathogenesis. Am J Surg Pathol. 2017 Oct; 41(10):1347-1363.
    View on PubMed
  12. Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, Giaccia AJ, Winslow MM. BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Cancer Discov. 2017 10; 7(10):1184-1199.
    View on PubMed
  13. Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator. Am J Surg Pathol. 2017 Jul; 41(7):865-876.
    View on PubMed
  14. Bove KE, Sheridan R, Fei L, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim G, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC. Hepatic Hilar Lymph Node Reactivity at Kasai Portoenterostomy for Biliary Atresia: Correlations With Age, Outcome, and Histology of Proximal Biliary Remnant. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):29-40.
    View on PubMed
  15. Ivry SL, Sharib JM, Dominguez DA, Roy N, Hatcher SE, Yip-Schneider MT, Schmidt CM, Brand RE, Park WG, Hebrok M, Kim GE, O'Donoghue AJ, Kirkwood KS, Craik CS. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clin Cancer Res. 2017 Aug 15; 23(16):4865-4874.
    View on PubMed
  16. Kim SS, Kim GE, Ko AH. A Patient with HIV-Associated Metastatic Anal Squamous Cell Carcinoma Receiving Multimodality Therapy with Curative Intent: Case Report and Review of the Literature. J Gastrointest Cancer. 2017 Mar; 48(1):94-99.
    View on PubMed
  17. Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, Finegold MJ, Finn LS, Kim GE, Lovell MA, Magid MS, Melin-Aldana H, Ranganathan S, Shehata BM, Wang LL, White FV, Chen Z, Spino C. Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study. Am J Surg Pathol. 2016 12; 40(12):1601-1615.
    View on PubMed
  18. Reid MD, Balci S, Ohike N, Xue Y, Kim GE, Tajiri T, Memis B, Coban I, Dolgun A, Krasinskas AM, Basturk O, Kooby DA, Sarmiento JM, Maithel SK, El-Rayes BF, Adsay V. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases. Mod Pathol. 2016 12; 29(12):1575-1585.
    View on PubMed
  19. Gonzalez RS, Bagci P, Basturk O, Reid MD, Balci S, Knight JH, Kong SY, Memis B, Jang KT, Ohike N, Tajiri T, Bandyopadhyay S, Krasinskas AM, Kim GE, Cheng JD, Adsay NV. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Mod Pathol. 2016 11; 29(11):1358-1369.
    View on PubMed
  20. Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? J Surg Oncol. 2016 Oct; 114(5):587-596.
    View on PubMed

Go to UCSF Profiles, powered by CTSI